MASS SCREENING TOOL OF COVID-19

     Certified

Manufactured in Singapore

IgM/IgG Serology Rapid Test that can screen:

  1. Symptomatic patients
  2. Asymptomatic patients
  3. Recovered patients who developed immunity to Covid-19

 

Smart COVID-19 IgM / IgG RDT

European Union European Economic Community Ce Mark College Logo ... Certified


Finger Prick RAPID Test

 QUICK Result in 10 mins

 

 SuperB Accuracy: 97.51%

Smart COVID-19 IgM/IgG RDT
is a lateral flow chromatographic immunoassay for the qualitative detection of IgM and IgG antibodies to COVID-19 virus (SARS-CoV-2) in 

  • serum
  • plasma
  • whole blood

How Smart COVID-19 IgM / IgG Rapid Test works

Several Advantages of rapid serology Test:

No equipment needed, can be done anywhere

Simple steps: anyone can be trained in few minutes

Quick result within 10 minutes.

 

Finger prick testing; very low risk of exposure (no blood or swab collection / transportation required)

 

Most appropriate for community screening, remote areas and in resource limited settings

Highly cost-effective: can screen large population at a fraction of the cost of RT-PCR

High capacity: hundreds of thousand people can be tested in a day

Features

Benefits

Patented Laminated test device design

  • Offers longer test performance for up to 7 days after exposure to air
  • Much lighter & more compact packaging
  • Easier transportation, storage & disposal

Rapid assay & results

Quick results with 10 mins test time – Fast results for timely treatment.

Simple steps with no equipment required

Easy to deploy in small clinics or in resource limited facilities

Excellent performance

Sensitivity: 90.85%
Specificity: 100.00%
Accuracy: 97.51%

IgM & IgG test lines

Test detects & differentiates IgM & IgG antibodies to SARS-CoV-2

  • IgM antibodies provide earlier detection of diseases than IgG.
  • IgG antibodies can confirm even recovered patients

Compatible with serum, plasma & whole blood 

Enables all kind of home, clinical or laboratory testing

Engraved Individual QR coded test device

Enables data management of product & patient information
Allows traceability and data collection for record review & retrieval

BIOTECHS ARE BATTLING TO MAKE THE FIRST GOOD BLOOD TEST FOR COVID-19

Antibody tests are at the forefront to assess who has potentially built up some immunity

Most test developers tout their products as performing very accurately when properly used.
…”If you see the brochure of every company, it’s 99%”…

In reality, the test often don’t perform so well in the hands of inexperienced users who are often toiling in sub-optimal conditions…

Source, Bloomberg April 17, 2020, 12.00 PM GMT+8

https://www.bloomberg.com/news/articles/2020-04-17/coronavirus-tests-biotechs-battle-to-make-first-good-blood-test

ENGRAVED DISTINCTIVE QR CODE

Optional tool for facilitating epidemiological population studies and proper auditing of Govt/ NGO test drives

Mobile and PC based apps to interpret and decode diagnostic devices for test results

Eliminate human-induced error in writing, recording and interpreting test results

Provide platform to interconnect with Medical Record System for product, process and user history tractability

This is the time to act for humanity..

Our heart goes for those who are losing their health, losing their income and losing their freedom to this invisible force.

At this time of unprecedented crisis, we want to make this inexpensive, accurate and quick test to be available to everyone.

We believe that this first class product to be available to various government bodies (and anyone else) at as much affordable prices as feasible so that they can possibly save many more lives with the same resource allocation.

All inquiries and assistance is welcome 

covid@zencare.com.sg

 

Copyright@Zen Care Pte Ltd